Searching for just a few words should be enough to get started. If you need to make more complex queries, use the tips below to guide you.
Article type: Research Article
Authors: Kimura, Akioa; * | Sakurai, Takeoa | Yamada, Megumia | Koumura, Akihiroa | Hayashi, Yuichia | Tanaka, Yujia | Hozumi, Isaoa | Ohtaki, Hirofumib | Chousa, Mitsuhirob | Takemura, Masaob | Seishima, Mitsurub | Inuzuka, Takashia
Affiliations: [a] Departments of Neurology and Geriatrics, Gifu University Graduate School of Medicine, Gifu City, Japan | [b] Department of Informative Clinical Medicine, Gifu University Graduate School of Medicine, Gifu City, Japan
Correspondence: [*] Correspondence to: Dr. Akio Kimura, Department of Neurology and Geriatrics, Gifu University Graduate School of Medicine, Gifu, 1-1 Yanagido, 501-1194 Gifu, Japan. Tel.: +81 58 230 6253; Fax: +81 58 230 6256; E-mail: [email protected].
Abstract: Recent studies suggest that microvascular abnormalities are involved in pathology and progression of Alzheimer's disease. The purpose of this study was to examine the presence of antibodies against cerebral microvascular endothelial cells specific for Alzheimer's disease, and to evaluate the association of these antibodies with cognitive impairment. The study included patients with Alzheimer's disease (age ≥60 years; 24 patients), control subjects without neurological diseases (age ≥60 years; 19 subjects), patients with multiple sclerosis (all ages; 17 patients), and healthy control subjects (age <40 years; 18 subjects). Serum was analyzed with 2-dimensional electrophoresis and Western blot, with cultured human brain microvascular endothelial cells as the antigen source. The anti-Tom40 antibody was identified significantly more frequently in patients with Alzheimer's disease than control subjects or patients with multiple sclerosis. In patients with Alzheimer's disease, the mean scores for the Mini-Mental State Examination were significantly lower for patients who were positive for anti-Tom40 antibody than those who were negative for anti-Tom40 antibody. In summary, the anti-Tom40 antibody is significantly associated with cognitive impairment in patients with Alzheimer's disease.
Keywords: Antigen, cognition, dementia, endothelial cell, mitochondrion, pathogenesis
DOI: 10.3233/JAD-2011-111343
Journal: Journal of Alzheimer's Disease, vol. 29, no. 2, pp. 373-377, 2012
IOS Press, Inc.
6751 Tepper Drive
Clifton, VA 20124
USA
Tel: +1 703 830 6300
Fax: +1 703 830 2300
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
IOS Press
Nieuwe Hemweg 6B
1013 BG Amsterdam
The Netherlands
Tel: +31 20 688 3355
Fax: +31 20 687 0091
[email protected]
For editorial issues, permissions, book requests, submissions and proceedings, contact the Amsterdam office [email protected]
Inspirees International (China Office)
Ciyunsi Beili 207(CapitaLand), Bld 1, 7-901
100025, Beijing
China
Free service line: 400 661 8717
Fax: +86 10 8446 7947
[email protected]
For editorial issues, like the status of your submitted paper or proposals, write to [email protected]
如果您在出版方面需要帮助或有任何建, 件至: [email protected]